Evropska unija - angleščina - EMA (European Medicines Agency)

novartis europharm limited - deferasirox - beta-thalassemia; iron overload - all other therapeutic products - exjade is indicated for the treatment of chronic iron overload due to frequent blood transfusions (≥ 7 ml/kg/month of packed red blood cells) in patients with beta thalassaemia major aged six years and older.exjade is also indicated for the treatment of chronic iron overload due to blood transfusions when deferoxamine therapy is contraindicated or inadequate in the following patient groups:in patients with beta thalassaemia major with iron overload due to frequent blood transfusions (≥ 7 ml/kg/month of packed red blood cells) aged two to five years;in patients with beta thalassaemia major with iron overload due to infrequent blood transfusions (< 7 ml/kg/month of packed red blood cells) aged two years and older;in patients with other anaemias aged two years and older.exjade is also indicated for the treatment of chronic iron overload requiring chelation therapy when deferoxamine therapy is contraindicated or inadequate in patients with non-transfusion-dependent thalassaemia syndromes aged 10 years and older.

Kanada - angleščina - Health Canada

novartis pharmaceuticals canada inc - deferasirox - tablet for suspension - 125mg - deferasirox 125mg - heavy metal antagonists

Kanada - angleščina - Health Canada

novartis pharmaceuticals canada inc - deferasirox - tablet for suspension - 250mg - deferasirox 250mg - heavy metal antagonists

Kanada - angleščina - Health Canada

novartis pharmaceuticals canada inc - deferasirox - tablet for suspension - 500mg - deferasirox 500mg - heavy metal antagonists

Kanada - angleščina - Health Canada

teva canada limited - deferasirox - tablet for suspension - 125mg - deferasirox 125mg - heavy metal antagonists

Kanada - angleščina - Health Canada

teva canada limited - deferasirox - tablet for suspension - 250mg - deferasirox 250mg - heavy metal antagonists

Kanada - angleščina - Health Canada

teva canada limited - deferasirox - tablet for suspension - 500mg - deferasirox 500mg - heavy metal antagonists

Kanada - angleščina - Health Canada

novartis pharmaceuticals canada inc - deferasirox - tablet - 90mg - deferasirox 90mg - heavy metal antagonists

Kanada - angleščina - Health Canada

novartis pharmaceuticals canada inc - deferasirox - tablet - 180mg - deferasirox 180mg - heavy metal antagonists

Kanada - angleščina - Health Canada

novartis pharmaceuticals canada inc - deferasirox - tablet - 360mg - deferasirox 360mg - heavy metal antagonists